ID
36217
Beschrijving
Study ID: 101963 Clinical Study ID: SCA101963 Study Title: A randomised, blinded, parallel group study to investigate the potential pharmacokinetic interaction between lamotrigine and risperidone in healthy, non-smoking, male volunteers. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: lamotrigine Trade Name: Lamictal XR,Lamictal,LAMICTIN Study Indication: Schizophrenia
Trefwoorden
Versies (1)
- 22-04-19 22-04-19 -
Houder van rechten
GlaxoSmithKline
Geüploaded op
22 april 2019
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 3.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Potential Pharmacokinetic Interaction between Lamotrigine and Risperidone; 101963
Study Conclusion
- StudyEvent: ODM
Beschrijving
Study Conclusion
Alias
- UMLS CUI-1
- C1707478
- UMLS CUI-2
- C0008972
Beschrijving
Report completion date; Patient withdrawn from trial, Date in time
Datatype
date
Alias
- UMLS CUI [1]
- C1549507
- UMLS CUI [2,1]
- C0422727
- UMLS CUI [2,2]
- C0011008
Beschrijving
Withdraw, Time
Datatype
time
Alias
- UMLS CUI [1,1]
- C2349954
- UMLS CUI [1,2]
- C0040223
Beschrijving
Subject withdrawn from trial
Datatype
boolean
Alias
- UMLS CUI [1]
- C0422727
Beschrijving
Subject withdrawn from trial, Indication
Datatype
text
Alias
- UMLS CUI [1,1]
- C0422727
- UMLS CUI [1,2]
- C3146298
Similar models
Study Conclusion
- StudyEvent: ODM
C0008972 (UMLS CUI-2)
C0422727 (UMLS CUI [2,1])
C0011008 (UMLS CUI [2,2])
C0040223 (UMLS CUI [1,2])
C3146298 (UMLS CUI [1,2])
Geen commentaren